AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Euroglipt M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Efrosine Healthcare Private Limited

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Euroglipt M 500mg/50mg Tablet

Combiflex DM 500mg/50mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like nephropathy and vision impairment, potentially lowering the risk of cardiovascular events. Combiflex DM may be administered independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and consistent exercise. Dosage is personalized based on your health status, glucose readings, and current medications. Ingesting it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under physician guidance. Effective blood sugar control minimizes long-term complications. Maintaining your prescribed diet and exercise regimen is crucial throughout treatment. Lifestyle significantly influences diabetes management. Commonly reported side effects include diarrhea, nausea, vomiting, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; understanding its symptoms and management is essential. This medication isn't universally suitable. Prior to use, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should consult their doctor before commencing treatment. Drug interactions are possible; disclose all medications to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your physician will monitor kidney function and blood glucose levels throughout your treatment.

Primary Ingredients of Euroglipt M 500mg/50mg Tablet

There is no text provided to rephrase.

Uses of Euroglipt M 500mg/50mg Tablet

Managing Type 2 Diabetes

Major Benefits of Euroglipt M 500mg/50mg Tablet:

Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the Euroglipt M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption should coincide with a meal.

Common Side effects of Euroglipt M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Euroglipt M 500mg/50mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Euroglipt M 500mg/50mg Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. Administer this medication with a meal.

How Euroglipt M 500mg/50mg Tablet works:

Each Euroglipt M 500mg/50mg tablet contains a dual-action formulation of two distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Euroglipt M 500mg/50mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Euroglipt M 500mg/50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any hazards before prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Euroglipt M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by abnormally low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when taking Euroglipt M 500mg/50mg tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should likely refrain from using Euroglipt M 500mg/50mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Euroglipt M 500mg/50mg Tablet :

Should you forget a Euroglipt M 500mg/50mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Euroglipt M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Euroglipt M 500mg/50mg Tablet

Euroglipt 500mg/50mg tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source like glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Euroglipt M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's advice.
Euroglipt M 500mg/50mg Tablets are contraindicated in patients allergic to any ingredient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Euroglipt M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Euroglipt M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Euroglipt M 500mg/50mg Tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Euroglipt M 500mg/50mg tablets as directed by your doctor is safe. However, even with correct usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (if also taking insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Euroglipt M 500mg/50mg Ta...
109
MRP 133
18% off